Workflow
psychedelic class treatments
icon
Search documents
Neuronetics(STIM) - 2025 Q4 - Earnings Call Transcript
2026-03-17 13:32
Neuronetics (NasdaqGM:STIM) Q4 2025 Earnings call March 17, 2026 08:30 AM ET Company ParticipantsAdam Maeder - Managing Director, Equity ResearchCory Anderson - CTODaniel Stauder - Director, Equity ResearchKeith Sullivan - President, and CEOMark Klausner - Managing PartnerSteven Pfanstiel - EVP, CFO, and TreasurerConference Call ParticipantsWilliam Plovanic - Managing Director, Equity Research Medical Technology AnalystOperatorLadies and gentlemen, thank you for standing by, and welcome to the Neuronetics R ...